One Ascent Family Office, LLC Gilead Sciences, Inc. Transaction History
One Ascent Family Office, LLC
- $107 Million
- Q1 2025
A detailed history of One Ascent Family Office, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, One Ascent Family Office, LLC holds 8,984 shares of GILD stock, worth $920,860. This represents 0.94% of its overall portfolio holdings.
Number of Shares
8,984
Previous 5,113
75.71%
Holding current value
$920,860
Previous $472,000
113.14%
% of portfolio
0.94%
Previous 0.86%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,284Shares Held
996MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$12.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.1 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.6 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.49 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $128B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...